BRD2 and amenorrhea: Nowadays, we have more precise and reliable methods to assess chemotherapy-induced gonadal toxicity (FSH, LH, estradiol levels) and fertility potential (AMH and AFC).[17] Aside from the timing of amenorrhea onset, the strength of the hypothesized correlation relies also on the variation of fertility markers during treatment.